Mark
Researcher
Microbiology
swedish brain power
Sweden
Biography
Dr. Mark joined the Inflammation research group at Pfizer. With Pfizer, his research has focused on the development of treatments for osteoarthritis, rheumatoid arthritis and autoimmune diseases. His areas of interest have been in novel approaches to kinase inhibition and the investigation of modulators for inflammatory lipid signaling pathways.
Research Interest
Microbiology
